Follow Us on Google News
NAFDAC explains position on claims for COVID-19 remedies
The National Agency for Food and Drug Administration and Control (NAFDAC) has said that the rush to mitigate the mortality and morbidly resulting from the COVID 19 pandemic has resulted in acceleration of product development, repurposing of formulations, off label use of therapeutics and the search for a vaccine to prevent COVID 19.
Nkechi Onyedika-Ugoeze, Abuja
